Display options
Cite
Hadzitheodorou C, Moss RA, Kennedy TJ, et al. Neoadjuvant Chemotherapy and Adjuvant Chemoradiation Therapy in the Treatment of Resected Gastric Adenocarcinoma: A Case Series. Case Rep Oncol. 2017;10(1):308-315doi: 10.1159/000464280.
Hadzitheodorou, C., Moss, R. A., Kennedy, T. J., & Jabbour, S. K. (2017). Neoadjuvant Chemotherapy and Adjuvant Chemoradiation Therapy in the Treatment of Resected Gastric Adenocarcinoma: A Case Series. Case reports in oncology, 10(1), 308-315. https://doi.org/10.1159/000464280
Hadzitheodorou, Christina, et al. "Neoadjuvant Chemotherapy and Adjuvant Chemoradiation Therapy in the Treatment of Resected Gastric Adenocarcinoma: A Case Series." Case reports in oncology vol. 10,1 (2017): 308-315. doi: https://doi.org/10.1159/000464280
Hadzitheodorou C, Moss RA, Kennedy TJ, Jabbour SK. Neoadjuvant Chemotherapy and Adjuvant Chemoradiation Therapy in the Treatment of Resected Gastric Adenocarcinoma: A Case Series. Case Rep Oncol. 2017 Apr 04;10(1):308-315. doi: 10.1159/000464280. eCollection 2017. PMID: 28512415; PMCID: PMC5422732.
Copy Download .nbib Format: NLM
Share it on

Case Rep Oncol. 2017 Apr 04;10(1):308-315. doi: 10.1159/000464280. eCollection 2017.

Neoadjuvant Chemotherapy and Adjuvant Chemoradiation Therapy in the Treatment of Resected Gastric Adenocarcinoma: A Case Series.

Case reports in oncology

Christina Hadzitheodorou, Rebecca A Moss, Timothy J Kennedy, Salma K Jabbour

Affiliations

  1. aDepartment of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA.
  2. bDivision of Medical Oncology, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.
  3. cBristol-Myers Squibb, Global Clinical Research, Lawrence Township, NJ, USA.
  4. dDivision of Surgical Oncology, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA.

PMID: 28512415 PMCID: PMC5422732 DOI: 10.1159/000464280

Abstract

The treatment of gastric cancer requires a multimodal approach to decrease the risk of locoregional and distant recurrence. The optimal timing of chemotherapy, surgery, and radiation therapy continues to be explored in ongoing trials. In the United States, surgical resection is often followed by adjuvant chemoradiation therapy or by a combination of neoadjuvant and adjuvant chemotherapy. Here we report on 4 patients with resected gastric adenocarcinoma who were treated with a combination of these 2 approaches, receiving neoadjuvant chemotherapy followed by adjuvant chemoradiation therapy.

Keywords: Adjuvant therapy; Chemoradiation; Chemotherapy; Gastric cancer; Neoadjuvant therapy

References

  1. BMC Cancer. 2015 Jul 21;15:532 - PubMed
  2. J Clin Oncol. 2015 Oct 1;33(28):3130-6 - PubMed
  3. World J Gastrointest Oncol. 2015 Aug 15;7(8):102-10 - PubMed
  4. Cancer. 1997 Dec 15;80(12):2333-41 - PubMed
  5. N Engl J Med. 2007 Nov 1;357(18):1810-20 - PubMed
  6. Lancet. 2012 Jan 28;379(9813):315-21 - PubMed
  7. J Clin Oncol. 2012 Jul 1;30(19):2327-33 - PubMed
  8. World J Gastroenterol. 2015 Jun 28;21(24):7343-8 - PubMed
  9. N Engl J Med. 2001 Sep 6;345(10):725-30 - PubMed
  10. BMC Cancer. 2011 Aug 02;11:329 - PubMed
  11. N Engl J Med. 2006 Jul 6;355(1):11-20 - PubMed
  12. Ann Surg Oncol. 2015 Sep;22(9):2965-71 - PubMed

Publication Types